FOSTER DYKEMA CABOT & PARTNERS, LLC

Position in LLY — ELI LILLY & Co

CIK 2011882 WALTHAM, MA

Position in LLY

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$33,614,028

+$7,793,325 QoQ

Shares Held

28,025

-0.2% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

3.09%

of 13F equity value

Holder Rank

#666

of 4,605 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FOSTER DYKEMA CABOT & PARTNERS, LLC holds $37,893,315 across 11 Drug Manufacturers - General names. LLY ranks #1 (88.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	28,025	$33,614,028
2	JNJ	Johnson & Johnson	5,153	$1,308,707
3	MRK	Merck & Co., Inc.	8,626	$1,108,441
4	ABBV	AbbVie Inc.	3,815	$960,006
5	NVO	Novo Nordisk A S	4,526	$216,976
6	NVS	Novartis AG	1,094	$171,451
7	AZN	Astrazeneca PLC	820	$155,488
8	AMGN	Amgen Inc	420	$152,090

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$33,614,028	28,025	-0.2%	Shares	Sole	2026-08-11
2026-03-31	$25,820,703	28,073	-0.2%	Shares	Sole	2026-05-14
2025-12-31	$30,216,780	28,117	-6.5%	Shares	Sole	2026-02-12
2025-09-30	$22,950,277	30,079	-0.4%	Shares	Sole	2025-11-12
2025-06-30	$23,541,026	30,199	-2.7%	Shares	Sole	2025-08-12
2025-03-31	$25,622,205	31,023	-7.6%	Shares	Sole	2025-05-09
2024-12-31	$25,908,320	33,560	-21.4%	Shares	Sole	2025-02-13
2024-09-30	$37,850,014	42,723	-2.3%	Shares	Sole	2024-11-12
2024-06-30	$39,600,415	43,739	-0.5%	Shares	Sole	2024-08-14
2024-03-31	$34,192,119	43,951	-11.1%	Shares	Sole	2024-05-10
2023-12-31	$28,824,228	49,448	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.